Genmab A/S (GNMSF)
376.00
-20.97
(-5.28%)
USD |
OTCM |
Oct 06, 16:00
Genmab Price to Book Value : 3.768 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 3.768 |
| October 05, 2026 | 3.978 |
| October 02, 2026 | 3.558 |
| October 01, 2026 | 3.558 |
| September 30, 2026 | 3.558 |
| September 29, 2026 | 3.558 |
| September 28, 2026 | 3.558 |
| September 25, 2026 | 3.538 |
| September 24, 2026 | 3.475 |
| September 23, 2026 | 3.395 |
| September 22, 2026 | 3.508 |
| September 21, 2026 | 3.438 |
| September 18, 2026 | 3.438 |
| September 17, 2026 | 3.438 |
| September 16, 2026 | 3.418 |
| September 15, 2026 | 3.397 |
| September 14, 2026 | 3.300 |
| September 11, 2026 | 3.300 |
| September 10, 2026 | 3.300 |
| September 09, 2026 | 3.300 |
| September 08, 2026 | 3.300 |
| September 04, 2026 | 3.300 |
| September 03, 2026 | 3.388 |
| September 02, 2026 | 3.388 |
| September 01, 2026 | 3.388 |
| Date | Value |
|---|---|
| August 31, 2026 | 3.388 |
| August 28, 2026 | 3.388 |
| August 27, 2026 | 3.388 |
| August 26, 2026 | 3.377 |
| August 25, 2026 | 3.377 |
| August 24, 2026 | 3.284 |
| August 21, 2026 | 3.377 |
| August 20, 2026 | 3.357 |
| August 19, 2026 | 3.207 |
| August 18, 2026 | 3.207 |
| August 17, 2026 | 3.207 |
| August 14, 2026 | 3.113 |
| August 13, 2026 | 3.113 |
| August 12, 2026 | 3.122 |
| August 11, 2026 | 3.122 |
| August 10, 2026 | 3.122 |
| August 07, 2026 | 3.122 |
| August 06, 2026 | 2.956 |
| August 05, 2026 | 2.906 |
| August 04, 2026 | 2.904 |
| August 03, 2026 | 2.826 |
| July 31, 2026 | 2.898 |
| July 30, 2026 | 2.898 |
| July 29, 2026 | 2.898 |
| July 28, 2026 | 2.898 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ascendis Pharma A/S | 9.066 |
| Zealand Pharma A/S | 0.9667 |
| Bavarian Nordic A/S | 1.251 |
| Evaxion AS | 2.748 |
| ACADIA Pharmaceuticals, Inc. | 2.568 |
Price to Book Value Related Metrics
| PE Ratio | 29.70 |
| PS Ratio | 5.800 |
| Price to Free Cash Flow | 26.90 |
| Price | 376.00 |
| Earnings Yield | 3.37% |
| Market Cap | 22.45B |
| Operating PE Ratio | 17.96 |
| Normalized PE Ratio | 24.35 |